Serum fetuin-A concentration predicts glycaemic outcomes in people with prediabetes: A prospective study from eastern India

Diabetic Medicine

Volumn 31, Issue 12, 2014, Pages 1594-1599

  Dutta, D ^a   Mondal, S A ^a   Kumar, M ^a   Hasanoor Reza, A H ^a   Biswas, D ^a   Singh, P ^a   Chakrabarti, S ^a   Mukhopadhyay, S ^a  

^a INSTITUTE OF POST GRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; FETUIN A; INSULIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; 25-HYDROXYVITAMIN D; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IL1B PROTEIN, HUMAN; IL6 PROTEIN, HUMAN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; VITAMIN D;

ADULT; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE COURSE; ECHOGRAPHY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INDIA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NONALCOHOLIC FATTY LIVER; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PREVALENCE; PROTEIN BLOOD LEVEL; RISK FACTOR; ANALOGS AND DERIVATIVES; DIABETES MELLITUS, TYPE 2; INSULIN RESISTANCE; LONGITUDINAL STUDY; METABOLISM; NON-ALCOHOLIC FATTY LIVER DISEASE; PREDIABETIC STATE; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY;

ADULT; ALPHA-2-HS-GLYCOPROTEIN; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; FEMALE; HUMANS; INDIA; INSULIN RESISTANCE; INTERLEUKIN-1BETA; INTERLEUKIN-6; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; PREDIABETIC STATE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; TRIGLYCERIDES; TUMOR NECROSIS FACTOR-ALPHA; VITAMIN D;

EID: 84911446544     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/dme.12539     Document Type: Article

References (20)

1. Schafer C, Heiss A, Schwarz A, Westenfeld R, Ketteler M, Floege J et al. The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest 2003; 112: 357-366.
2. Koluman BU, Mutluay R, Derici UB, Arinsoy T, Senlik Z, Bahar B et al. Association between osteoprotegerin, fetuin-A carotid intima media thickness, and urinary albumin excretion in type-2 diabetes. Clin Nephrol 2013; 80: 9-16.
3. Zhao ZW, Lin CG, Wu LZ, Luo YK, Fan L, Dong XF et al. Serum fetuin-A levels are associated with the presence and severity of coronary artery disease in patients with type-2 diabetes. Biomarkers 2013; 18: 160-164.
4. Jensen MK, Bartz TM, Mukamal KJ, Djoussé L, Kizer JR, Tracy RP et al. Fetuin-A, type-2 diabetes, and risk of cardiovascular disease in older adults: the cardiovascular health study. Diabetes Care 2013; 36: 1222-1228.
5. Lorant DP, Grujicic M, Hoebaus C, Brix JM, Hoellerl F, Schernthaner G et al. Fetuin-A levels are increased in patients with type-2 diabetes and peripheral arterial disease. Diabetes Care 2011; 34: 156-161.
6. Inoue K, Wada J, Eguchi J, Nakatsuka A, Teshigawara S, Murakami K et al. Urinary fetuin-A is a novel marker for diabetic nephropathy in type-2 diabetes identified by lectin microarray. PLoS One 2013; 8: e77118.
7. Pal D, Dasgupta S, Kundu R, Maitra S, Das G, Mukhopadhyay S et al. Fetuin-A acts as an endogenous ligand of TLR4 to prom-ote lipid-induced insulin resistance. Nat Med 2012; 18: 1279-1285.
8. Dasgupta S, Bhattacharya S, Biswas A, Majumdar SS, Mukhopadhyay S, Ray S et al. NF-kappaB mediates lipid-induced fetuin-A expression in hepatocytes that impairs adipocyte function effecting insulin resistance. Biochem J 2010; 429: 451-462.
9. Stefan N, Haring HU. The role of hepatokines in metabolism. Nat Rev Endocrinol 2013; 9: 144-152.
10. Ou HY, Yang YC, Wu HT, Wu JS, Lu FH, Chang CJ. Increased fetuin-A concentrations in impaired glucose tolerance with or without nonalcoholic fatty liver disease, but not impaired fasting glucose. J Clin Endocrinol Metab 2012; 97: 4717-4723.
11. Stefan N, Fritsche A, Weikert C, Boeing H, Joost HG, Häring HU et al. Plasma fetuin-A levels and the risk of type-2 diabetes. Diabetes 2008; 57: 2762-2767.
12. Ix JH, Wassel CL, Kanaya AM, Vittinghoff E, Johnson KC, Koster A et al. Health ABC Study. Fetuin-A and incident diabetes mellitus in older persons. JAMA 2008; 300: 182-188.
13. Sun Q, Cornelis MC, Manson JE, Hu FB. Plasma levels of fetuin-A and hepatic enzymes and risk of type 2 diabetes in women in the U.S. Diabetes 2013; 62: 49-55.
14. Dutta D, Choudhuri S, Mondal SA, Mukherjee S, Chowdhury S. Urine albumin creatinine ratio predicts prediabetes progression to diabetes and reversal to normoglycemia: Role of associated insulin resistance, inflammatory cytokines and low vitamin-D. J Diabetes 2013; 6: 316-322.
15. Osawa H, Morry Y. Sonographic diagnosis of fatty liver using a histogram technique that compares liver and renal cortical echo amplitudes. J Clin Ultrasound 1996; 24: 25-29.
16. Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A et al. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol 2006; 6: 33.
17. Ou HY, Yang YC, Wu HT, Wu JS, Lu FH, Chang CJ. Serum fetuin-A concentrations are elevated in subjects with impaired glucose tolerance and newly diagnosed type 2 diabetes. Clin Endocrinol 2011; 75: 450-455.
18. Dutta D, Mondal SA, Choudhuri S, Maisnam I, Hasanoor Reza AH, Bhattacharya B et al. Vitamin-D supplementation in prediabetes reduced progression to type 2 diabetes and was associated with decreased insulin resistance and systemic inflammation: An open label randomized prospective study from Eastern India. Diabetes Res Clinical Pract 2014; 103: e18-e23.
19. Palomer X, Gonzalez-Clemente JM, Blanco-Vaca F, Mauricio D. Role of vitamin D in the pathogenesis of type 2 diabetes mellitus. Diabetes Obes Metab 2008; 10: 185-197.
20. Price PA, Williamson MK, Nguyen TM, Than TN. Serum levels of the fetuin mineral complex correlate with artery calcification in the rat. J Biol Chem 2004; 279: 1594-1600.